Nature Reviews Neurology Contents: Volume 18 Number 2

In this Issue: Comment Research Highlights News & Views Reviews Perspectives

Nature Reviews Neurology Contents: Volume 18 Issue 2

Comment

Does antiherpetic antiviral therapy reduce the risk of dementia? Ruth F. Itzhaki Comment | 06 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00596-4

Research Highlights

Microglia, spreaders of Aβ seeds Ian Fyfe Research Highlight | 17 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00604-7

A machine learning model of HD progression Sarah Lempriere In Brief | 20 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00608-3

Change in stroke outcomes over 20 years Sarah Lempriere In Brief | 20 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00609-2

High rate of epilepsy in young individuals who died with COVID-19 Sarah Lempriere In Brief | 20 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00610-9

Exosomal microRNA is promising biomarker in PD Sarah Lempriere In Brief | 20 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00611-8

Intelligent, mobile stroke imaging Ian Fyfe Research Highlight | 21 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00614-5

Safety and efficacy of COVID-19 vaccines in people with neurological disorders Heather Wood Research Highlight | 09 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00603-8

Role for endogenous retrovirus in FTD Sarah Lemprière Research Highlight | 22 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00615-4

News & Views

Refining oxytocin therapy for autism: context is key Charles L. Ford & Larry J. Young News & Views | 08 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00602-9

Risk–benefit analysis of COVID-19 vaccines — a neurological perspective Colleen L. Lau & Ian Galea News & Views | 20 December 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00606-5

Reviews

Genetic generalized epilepsies in adults — challenging assumptions and dogmas Bernd J. Vorderwülbecke, Britta Wandschneider, Yvonne Weber & Martin Holtkamp Review Article | 26 November 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00583-9

Genetics of common cerebral small vessel disease Constance Bordes, Muralidharan Sargurupremraj, Aniket Mishra & Stéphanie Debette Review Article | 05 January 2022 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00592-8

Perspectives

Cognitive impairment and World Trade Centre-related exposures Sean A. P. Clouston , Charles B. Hall , Minos Kritikos , David A. Bennett , Steven DeKosky et al. Perspective | 18 November 2021 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00576-8

Neurogenetic disorders across the lifespan: from aberrant development to degeneration Richard A. Hickman, Sarah A. O'Shea, Mark F. Mehler & Wendy K. Chung Perspective | 05 January 2022 Nature Reviews Neurology 18 | doi:10.1038/s41582-021-00595-5

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Nature Reviews Neurology.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.